Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease

Digestive Diseases and Sciences

Volumn 59, Issue 4, 2014, Pages 760-768

  Sazuka, Sayuri ^a   Katsuno, Tatsuro ^a   Nakagawa, Tomoo ^a   Saito, Masaya ^a   Saito, Keiko ^a   Maruoka, Daisuke ^a   Matsumura, Tomoaki ^a   Arai, Makoto ^a   Miyauchi, Hideaki ^a   Matsubara, Hisahiro ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Collagen type I (ColI); CXC chemokine receptor 4 (CXCR4); Intercellular adhesion molecule 1 (ICAM1); Leukocyte specific protein 1 (LSP 1); Lipopolysaccharide (LPS)

Indexed keywords

CD45 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; COLLAGEN ANTIBODY; COLLAGEN TYPE 1 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE SPECIFIC PROTEIN 1 ANTIBODY; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CELL STIMULATION; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; CROHN DISEASE; FIBROCYTE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; LEUKOCYTE COUNT; MEDIATOR RELEASE; MONOCYTE CULTURE; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION;

CELLS, CULTURED; COLLAGEN TYPE I; CROHN DISEASE; FIBROBLASTS; FIBROSIS; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTESTINAL MUCOSA; RECEPTORS, CXCR4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897428518     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2813-8     Document Type: Article

References (24)

1. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, O'Connell PR. Fibrogenesis in Crohn's disease. Am J Gastroenterol. 2007;102:439-448. (Pubitemid 46160558)
2. Rieder F, Brenmoehl J, Leeb S, Scholmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut. 2007;56: 130-139. (Pubitemid 46044899)
3. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Curr Opin Gastroenterol. 2008;24:462-468.
4. Rieder F, Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009;6:228-235.
5. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71-81.
6. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11:427-435.
7. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol. 2004;36:598-606. (Pubitemid 38316817)
8. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest . 2007;87:858-870. (Pubitemid 47267815)
9. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci. 2003;60:1342-1350. (Pubitemid 36900518)
10. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol. 2010;38:548-556.
11. Uehara H, Nakagawa T, Katsuno T, et al. Emergence of fibrocytes showing morphological changes in the inflamed colonic mucosa. Dig Dis Sci. 2010;55:253-260.
12. Garcia-de-Alba C, Becerril C, Ruiz V, et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med. 2010;182:1144-1152.
13. Yang L, Scott PG, Dodd C, et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen. 2005;13:398-404. (Pubitemid 41060421)
14. Wu Y, Wang J, Scott PG, Tredget EE. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15:S18-S26. (Pubitemid 47301670)
15. Peng H, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Curr Opin Pharmacol. 2012;12:491-496.
16. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol . 2003;171:380-389. (Pubitemid 36745311)
17. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun. 2007;353:104-108. (Pubitemid 44958347)
18. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:588-594.
19. Mathai SK, Gulati M, Peng X, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 2010;90:812-823.
20. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004;114:438-446. (Pubitemid 39071616)
21. Balmelli C, Alves MP, Steiner E, et al. Responsiveness of fibrocytes to toll-like receptor danger signals. Immunobiology. 2007;212:693-699.
22. Pasternak BA, D'Mello S, Jurickova II, et al. Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. Inflamm Bowel Dis. 2010;16:856-869.
23. Zareie M, Singh PK, Irvine EJ, Sherman PM, McKay DM, Perdue MH. Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am J Pathol. 2001;158:1101-1109. (Pubitemid 32221802)
24. Johnson LA, Luke A, Sauder K, Moons DS, Horowitz JC, Higgins PD. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice. Inflamm Bowel Dis. 2012;18:460-471.